Lite Strategy, Inc. (LITS) is a Healthcare · Biotechnology company listed on NASDAQ. Price $1.11 (+6.73%), Market cap $0.04B, 52-week low–high $0.95 ~ $6.86.
Lite Strategy, Inc. a clinical-stage pharmaceutical company, focuses on the development of novel and differentiated therapies for the treatment of cancer. The company was formerly known as MEI Pharma, Inc. and changed its name to Lite Strategy, Inc. in September 2025. Lite Strategy, Inc. was incorporated in 2000 and is based in San Diego, California.
Financial statements, price targets, institutional (13F) holdings and related news for Lite Strategy, Inc. are updated in real time on BlackAll Trade.
Lite Strategy, Inc. trades at $1.11 (+6.73%). Real-time quotes and charts are available on BlackAll Trade.
Lite Strategy, Inc. has a market cap of about $0.04B.
Lite Strategy, Inc. a clinical-stage pharmaceutical company, focuses on the development of novel and differentiated therapies for the treatment of cancer. The company was formerly known as MEI Pharma,